SunnyBay BioTech, Inc.

FREMONT, CA · Founded 2022 · Biotech · Private

Targeted drug delivery system for anti-cancer therapeutics

Claim this profile

Follows are private to you and power your alerts

Updated · sunnybaybiotech.com

Sector
Biotech
Headquarters
FREMONT, CA
Founded
2022
Latest Form D
$2.2M, Jan 2023
Total capital
$2.2M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$2.2M
1 Form D · last Jan 2023
45 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
4 pending

Capital timeline

2023FEDERAL ↑EQUITY ↓Cumulative $2.2M1st Form D$2.2M
2023FEDERAL ↑EQUITY ↓Cumulative $2.2M1st Form D$2.2M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$2.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Feng Wang-JohanningExecutive Officer, DirectorNamed in SEC Form D filings
  • Gary JohanningExecutive OfficerNamed in SEC Form D filings
  • Peter ColabuonoDirectorNamed in SEC Form D filings
  • Xiangmin CuiDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 4
  • PendingHerv-k Antibody, Cell, Vaccine, And Drug TherapeuticsUSPTOApplication 18692760
  • PendingHerv-k Antibody TherapeuticsUSPTOApplication 18692754
  • PendingEndogenous Retroviruses For The Detection, Diagnosis, And Prognosis Of CancerUSPTOApplication 17995855
Show all 4 patent records
  • Herv-k Antibody, Cell, Vaccine, And Drug TherapeuticsMay 8, 2025 · Application 18692760Pending
  • Herv-k Antibody TherapeuticsNov 14, 2024 · Application 18692754Pending
  • Endogenous Retroviruses For The Detection, Diagnosis, And Prognosis Of CancerAug 17, 2023 · Application 17995855Pending
  • Herv-k Antibody TherapeuticsApplication PCTUS2022076624Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .